SMALL MOLECULE MODULATORS OF IL-17

The present invention relates to a compound according to formula I and pharmaceutically acceptable salts, hydrates, or solvates thereof. The invention further relates to said compounds for use in therapy, for example for the treatment of diseases such as autoimmune diseases, psoriasis, ankylosing sp...

Full description

Saved in:
Bibliographic Details
Main Authors SEITZBERG, Jimmi Gerner, ANDREWS, Mark David, DACK, Kevin Neil
Format Patent
LanguageEnglish
French
German
Published 26.01.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a compound according to formula I and pharmaceutically acceptable salts, hydrates, or solvates thereof. The invention further relates to said compounds for use in therapy, for example for the treatment of diseases such as autoimmune diseases, psoriasis, ankylosing spondylitis, spondyloarthritis or psoriatic arthritis, and to pharmaceutical compositions comprising said compounds.
Bibliography:Application Number: EP20200187785